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Identification of cell cycle–regulated genes 
periodically expressed in U2OS cells and their 
regulation by FOXM1 and E2F transcription 
factors
Gavin D. Granta, Lionel Brooks 3rda, Xiaoyang Zhanga, J. Matthew Mahoneya, Viktor Martyanova, 
Tammara A. Wooda, Gavin Sherlockb, Chao Chenga, and Michael L. Whitfielda
aDepartment of Genetics, Geisel School of Medicine at Dartmouth, Hanover, NH 03755; bDepartment of Genetics, 
Stanford University School of Medicine, Stanford, CA 94305
ABSTRACT We identify the cell cycle–regulated mRNA transcripts genome-wide in the oste-
osarcoma-derived U2OS cell line. This results in 2140 transcripts mapping to 1871 unique cell 
cycle–regulated genes that show periodic oscillations across multiple synchronous cell cycles. 
We identify genomic loci bound by the G2/M transcription factor FOXM1 by chromatin im-
munoprecipitation followed by high-throughput sequencing (ChIP-seq) and associate these 
with cell cycle–regulated genes. FOXM1 is bound to cell cycle–regulated genes with peak 
expression in both S phase and G2/M phases. We show that ChIP-seq genomic loci are re-
sponsive to FOXM1 using a real-time luciferase assay in live cells, showing that FOXM1 
strongly activates promoters of G2/M phase genes and weakly activates those induced in S 
phase. Analysis of ChIP-seq data from a panel of cell cycle transcription factors (E2F1, E2F4, 
E2F6, and GABPA) from the Encyclopedia of DNA Elements and ChIP-seq data for the DREAM 
complex finds that a set of core cell cycle genes regulated in both U2OS and HeLa cells are 
bound by multiple cell cycle transcription factors. These data identify the cell cycle–regulated 
genes in a second cancer-derived cell line and provide a comprehensive picture of the tran-
scriptional regulatory systems controlling periodic gene expression in the human cell division 
cycle.
INTRODUCTION
Examining the periodic expression patterns of the human cell cy-
cle using genomic approaches can provide a complete picture of 
one of the most tightly regulated processes in the life of a cell. 
This knowledge allows, in turn, the examination of how different 
regulators of the cell cycle machinery interact and affect the 
timing of cell cycle progression. This is especially important, as 
perturbations in cell cycle progression can lead to apoptosis or 
cancer.
The cell cycle has been studied extensively at the molecular 
level, and transcriptional programs have been measured and ana-
lyzed using microarray technology in budding yeast (Cho et al., 
1998; Spellman et al., 1998), fission yeast (Rustici et al., 2004; Oliva 
et al., 2005; Peng et al., 2005), bacteria (Laub et al., 2000), primary 
human fibroblasts (Cho et al., 1998; Iyer et al., 1999; Bar-Joseph 
et al., 2008), mouse fibroblasts (Ishida et al., 2001), Arabidopsis 
(Menges et al., 2002, 2005), the human keratinocyte cell line HaCaT 
(Pena-Diaz et al., 2013), and HeLa cells (Crawford and Piwnica-
Worms, 2001; Whitfield et al., 2002; Sadasivam et al., 2012). The 
analysis of cell cycle–regulated gene expression in fibroblasts and 
HeLa cells suggests both commonality and cell-type specificity in 
the cell cycle–regulated gene expression programs of human cells. 
Here we provide the full complement of cell cycle–regulated genes 
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Chen et al., 2011; Lok et al., 2011; Ahmed et al., 2012; Lynch et al., 
2012; Xue et al., 2012).
Although FOXM1 is perhaps the best-studied forkhead box pro-
tein involved in cell cycle control, there are a number of others that 
have roles in cell cycle progression. FOXK1 and FOXJ3 are required 
for cell cycle progression in U2OS cells, as determined in both live-
cell luminescence assays (Grant et al., 2012) and genome-wide small 
interfering RNA (siRNA) screens (Mukherji et al., 2006; Kittler et al., 
2007). In addition, there are a number of other FOX genes that re-
sult in cell cycle phenotypes when knocked down in siRNA screens, 
including FOXA2, FOXA1, and FOXL2 (Mukherji et al., 2006; Kittler 
et al., 2007).
Here we identify the cell cycle–regulated genes in U2OS cells 
after synchronization using either a double-thymidine block or a 
thymidine–nocodazole block. We identify 2140 transcripts mapping 
to 1871 unique cell cycle–regulated genes and analyze FOXM1 ge-
nomic loci by genome-wide chromatin immunoprecipitation fol-
lowed by high-throughput sequencing (ChIP-seq). We show that 
FOXM1 is bound to many genes involved in the G2- to M-phase 
transition, as well as a number of genes involved in DNA replication. 
Inclusion of ChIP-seq data for E2F1, 4, and 6 from the Encyclopedia 
of DNA Elements (ENCODE) project, FOXK1 (Grant et al., 2012), 
and the DREAM complex (Sadasivam et al., 2012) provides a com-
prehensive picture of the transcriptional regulatory system control-
ling periodic gene expression in the human cell division cycle.
RESULTS
We identified the full complement of genes periodically expressed 
across multiple synchronous cell division cycles in the commonly 
studied human U2OS osteosarcoma-derived cell line (Ponten and 
Saksela, 1967; Laoukili et al., 2005). This extends and contrasts 
with periodic, cell cycle–regulated gene expression data from 
three additional human cell lines: HeLa cells (Whitfield et al., 2002; 
Sadasivam et al., 2012), primary foreskin fibroblasts (Cho et al., 
2001; Bar-Joseph et al., 2008), and HaCaT cells (Pena-Diaz et al., 
2013).
Identification of periodically expressed transcripts
Two complementary methods were used to obtain synchronous 
populations of U2OS cells. The first is a thymidine–thymidine (Thy-
Thy) synchronization that arrests cells at the G1/S boundary, and the 
second is a thymidine–nocodazole (Thy-Noc) synchronization that 
arrests cells in mitosis. Each of these methods provides the best 
synchrony in the cell cycle phases that immediately follow the arrest. 
Thy-Thy provides the best synchrony for the G2 and M phases, and 
Thy-Noc provides the best synchrony in G1/S and S phases. Three 
Thy-Thy synchronization time courses were performed, which sam-
pled the population at 2-h intervals for 38 h (Thy-Thy 1) or 46 h 
(Thy-Thy 2 and Thy-Thy 3; Figure 1; all figures are available in blue/
yellow color format in Supplemental Figure S10). The Thy-Thy time 
courses measured gene expression across 2.5 synchronous cell 
cycles, traversing two complete cycles of S phase and mitosis, and 
into a third round of DNA replication. A fourth time course was per-
formed using the Thy-Noc synchronization protocol, and time points 
were collected at 2-h intervals for 44 h, which resulted in two full 
cycles of mitosis and S phase (Figure 1). Gene expression was mea-
sured genome-wide using these two complementary methods 
across four independent time courses, resulting in the analysis of 
multiple synchronous cell cycles.
The degree of synchrony in each cell cycle time course was moni-
tored by flow cytometry analysis of DNA content by propidium 
iodide staining (Supplemental Figure S1). In addition, cell lysates 
line U2OS. In addition, to shed light on cell cycle regulation, we 
determine the genome-wide binding patterns of FOXM1 and ana-
lyze publicly available data for additional cell cycle transcriptional 
regulators, thus providing an interpretive framework for the periodic 
gene expression program in U2OS cells.
DNA replication and mitosis are two major cellular events whose 
transcriptional programs must be precisely coordinated and exe-
cuted in order for a cell to successfully divide. To ensure that these 
two events are successfully completed in an orderly manner, there 
are regulatory mechanisms, ranging from transcriptional control 
(e.g., RB and pocket protein sequestration of E2Fs) to protein deg-
radation (e.g., anaphase-promoting complex), that assure that a cell 
progresses forward in the process and reversal does not occur. 
These processes, in turn, have their own systems of control and 
regulation. Transcription factors provide one aspect of this control, 
regulating the timing and levels of gene expression. One of these 
transcription factors, the G1/S-phase regulator E2F1, has been well 
studied, whereas the corresponding transcription factor for mitotic 
gene expression, FOXM1, has been less well studied (reviewed in 
Wierstra and Alves, 2007; Alvarez-Fernandez and Medema, 2013).
At the beginning of and throughout S phase, the E2F family of 
transcription factors regulates the expression of genes involved in 
initiation and continued replication of DNA (Johnson et al., 1994; 
Slansky and Farnham, 1996; Helin, 1998). As cells progress through 
S phase, the MuvB core complex (LIN9, LIN37, LIN52, LIN54, and 
RBBP4) dissociates from the DREAM complex (TFDP1, p130 [RBL2], 
E2F4, and the MuvB core complex) and binds to B-Myb (the B-Myb-
MuvB complex). This complex then binds to the promoters of PLK1 
and CCNB1, two genes expressed in G2 and mitosis, as well as a 
number of other mitotic cell cycle genes (Sadasivam et al., 2012). In 
late S phase, the transcription factor FOXM1 is recruited to these 
promoters by the B-Myb-MuvB complex before B-Myb dissociates 
from the complex and is degraded by the proteasome (Litovchick 
et al., 2007).
FOXM1 activates expression of genes critical for the proper pro-
gression of mitosis, including CCNB1, PLK1, CDC25B, CDC25C, 
AURKB, and BIRC5 (Kalinichenko et al., 2003; Kim et al., 2005; 
Laoukili et al., 2005; Wonsey and Follettie, 2005; Alvarez-Fernandez 
et al., 2010; Nakamura et al., 2010; Bonet et al., 2012; Down et al., 
2012; Sadasivam et al., 2012). In HeLa cells, FOXM1 mRNA is cell 
cycle regulated, with peak expression in G2 (Whitfield et al., 2002). 
The FOXM1 protein is also phosphorylated in M phase. These 
include multiple phosphorylation events involving multiple cyclin-
CDK complexes, including cyclin D1/Cdk4 (Wierstra and Alves, 
2006b, 2008), cyclin E/Cdk2 (Wierstra and Alves, 2006a, 2008), 
cyclin A/Cdk2 (Wierstra and Alves, 2006a, 2008; Laoukili et al., 
2008), cyclin A/Cdk1 (Wierstra and Alves, 2006a), and cyclin B1/
Cdk1 (Major et al., 2004; Chen et al., 2009), as well as phosphoryla-
tion by PLK1 (Chen et al., 2009). These modifications culminate in 
the destruction of FOXM1 protein during mitosis by the APC/C 
(Laoukili et al., 2008; Park et al., 2008). FOXM1 expression is often 
increased in different types of cancer, such as squamous cell carci-
noma (Calvisi et al., 2009; Chen et al., 2009; Gemenetzidis et al., 
2009; Waseem et al., 2010; Hui et al., 2012; Teh et al., 2013), rhab-
domyosarcoma (Wan et al., 2012), hepatocellular carcinoma (Liu 
et al., 2012; Xia et al., 2012), pancreatic cancer (Huang et al., 2012), 
glioblastoma (Liu et al., 2006), breast cancer (Madureira et al., 2006; 
Ahmad et al., 2010, 2011; Kwok et al., 2010; Bergamaschi et al., 
2011; Wang and Gartel, 2011; Park et al., 2012), and leukemia 
(Nakamura et al., 2010). FOXM1 has also been shown to drive ex-
pression of MMP2 and MMP9, which are implicated in metastases 
and tumor cell invasion (Wang et al., 2008; Ahmad et al., 2010; 
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Spellman et al., 1998; Whitfield et al., 2002). Table 1 gives examples 
of genes and their periodicity score (Supplemental Table S1).
To establish a cutoff for a cell cycle–regulated gene, we random-
ized the data either by rows or both rows and columns and repeated 
the analysis on the randomized data to estimate a false discovery 
rate (FDR). We selected a periodicity score of 2.65, which resulted in 
3568 periodically expressed probes with estimated FDR of 1.29% 
when randomizing by rows and columns and 3.67% when random-
izing by rows only. To estimate the false-negative rate (FNR), we 
used a list of known cell cycle–regulated genes (Whitfield et al., 
2002, Table 2). We determined the FNR at this cutoff to be 11%.
As in the prior analysis of HeLa cells, we found that a portion of 
the probes display a sinusoidal pattern in the first cell cycle but do 
were prepared and Western blots performed for well-characterized 
cell cycle–regulated proteins (CCNB1 and FOXM1; unpublished 
data). All data used in this study were from experiments that showed 
clear cell cycle synchrony using these two measures.
Periodically expressed genes were identified as previously de-
scribed (Whitfield et al., 2002). We collected and isolated total RNA 
from synchronous U2OS cells every 2 h for a minimum of 38 h and 
determined the expression of all genes in the genome using Agilent 
4 × 44,000–element DNA microarrays (41,000 probes representing 
19,637 unique Entrez GeneIDs). Each time course was analyzed 
independently.
To verify our ability to detect periodic cell cycle–regulated genes, 
we selected a set of known cell cycle–regulated genes from the lit-
erature previously shown to have peak expression in each of the five 
major phases of the cell cycle (G1/S, S, G2, G2/M, and M/G1; Figure 
1). Expression of these genes in each time course is shown with 
DNA replication and mitosis indicated (Figure 1). For G1/S, we ex-
amined CCNE1, CCNE2, E2F2, PCNA, and MCM2. For S phase, we 
selected genes involved in DNA replication or the packaging of 
newly replicated DNA, including HIST1H4B, HIST1H4C, SLBP, 
RRM2, and RFC4. G2 was represented by TOP2A, CDC2, CCNA2, 
and CCNF. G2/M included five genes required for mitosis: CCNB1, 
CCNB2, BUB1, BUB1B, and CDC25B. Following on the observation 
from Whitfield et al. (2002) that a set of genes showed peak expres-
sion during mitosis into G1, we selected three genes for the M/G1 
transition: RAD21, CDKN3, and PTTG1. These genes were aver-
aged to generate an idealized expression vector for each cell cycle 
phase (Figure 1B).
A Fourier transform (Whitfield et al., 2002) was used to generate 
a periodicity score for each gene. The periodicity score quantifies 
how periodic a gene is across each of the four time courses and is the 
magnitude of the sine and cosine components of the Fourier analysis 
(see Materials and Methods). The periodicity score for each gene was 
summed across the four time courses and then scaled by the highest 
correlation to one of five idealized vectors of the known cell cycle 
genes for each cell cycle phase (G1/S, S, G2, G2/M, M/G1; Figure 1; 
FIGURE 1: Periodic expression of well-characterized cell cycle genes. (A) Expression profiles of known periodically 
expressed genes for each of the four time courses. The purple bars indicate S phase, and black arrows indicate mitosis 
as estimated by flow cytometry or Western blots. (B) The idealized vector for each phase is the average expression of 
the known genes shown in A.
Rank Gene Periodicity score Maximum fold change
1 SHISA3 27.0 7
2 PIF1 26.5 4.5
4 KIF20A 23.5 6
7 PLK1 22.5 3
11 CCNB1 19.5 2.5
14 CCNE1 19.0 5.5
23 CENPE1 16.8 5
161 PCNA 9.15 3.5
964 CIT 4.90 1.5
1162 BRCA1 4.50 2
1288 PRIM1 4.28 2.5
2557 E2F1 3.12 2
The maximum fold change is the largest difference in peak-to-trough ratio for 
each gene rounded down to the nearest 0.5 fold change.
TABLE 1: Sample periodicity scores from selected cell cycle–
regulated genes.
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processes in each cluster. Genes involved in mitosis (M phase, p = 
6.6 × 10−42), including cyclins A2, B1, B2, and F, primarily fell into 
one large cluster, whereas genes involved in DNA replication sepa-
rated into three large clusters, each with weaker but still significant 
levels of enrichment for S-phase processes (DNA replication, p = 
1.4 × 10−10; DNA metabolic process, 1.4 × 10−6). The first cluster of 
S-phase genes includes four minichromosome maintenance pro-
teins (MCM 2, 3, 4, and 10), PCNA, CDT1, CHAF1A, CHAF1B, E2F2, 
and E2F8. The second cluster of DNA replication genes includes 
RMI1, DSCC1, and MCM6. The third and final DNA replication clus-
ter includes two more E2F genes, E2F1 and E2F7, PLK3, RMI2, 
CDC45L, RBBP8, DHFR, BRIP1, PRIM1, RRM2, and RFC4. A small 
but distinct cluster was found completely comprising histone genes 
(nucleosome assembly, p = 4.9 × 10−23). There was also a small clus-
ter of genes containing primarily heat shock proteins (labeled the 
HSP70 cluster), as well as the HSP70-binding protein BAG3, which 
has antiapoptotic properties (Takayama et al., 1999; Doong et al., 
2000; Romano et al., 2003a,b).
The overall patterns of gene expression reflect the fundamental 
biological processes necessary to duplicate a cell, such as DNA rep-
lication, DNA packaging, formation of the mitotic spindle, and mito-
sis. It includes not only the proteins required to perform these pro-
cesses (e.g., MCM proteins, the histones, proteins at the DNA 
replication fork, nucleotide biosynthesis, nucleosome assembly and 
mitotic genes), but also key regulators of those genes (e.g., E2F 
transcription factors, cyclins, and key kinases such as PLK). Each of 
these is coordinately regulated in a tightly controlled manner, with 
peak expression at their required points in the cell cycle and then 
reduced expression until they are needed the following cell cycle.
Cell cycle regulation by FOXM1
To understand the network of transcription factors controlling cell 
cycle–regulated gene expression and better understand the role of 
FOXM1 in the transcriptional program that regulates mitosis, we 
performed ChIP-seq for endogenous FOXM1 in asynchronous HeLa 
cells. IPs were performed in duplicate using an antibody against the 
endogenous FOXM1 (C20; Santa Cruz Biotechnology) and se-
quenced independently. As a conservative estimate of FOXM1 
binding, we focused the analysis on those ChIP-seq regions found in 
both ChIP-seq assays. The first sequencing analysis (run A) gave 
17.1 million sequence reads, with 8.4 million reads mapped (Hg 19), 
and the second sequencing analysis (run B) gave 17.0 million se-
quence reads, with 8.4 million mapped. Using the MACS module in 
Cistrome (Zhang et al., 2008; Liu et al., 2011; www.cistrome.com), 
we found 5727 peaks in A and 2849 peaks in B, with 2215 regions 
identified in both; these regions could be associated with 2367 
unique genes by the Gene Centered Annotation (GCA) module in 
Cistrome (Shin et al., 2009; Figure 4 and Supplemental Figure S4). 
We refer to these intersecting regions as FOXM1 genomic loci. Of 
the genomic loci, 36.8% were in promoter regions within 3000 base 
pairs upstream from the transcription start site, and 1.9% of 
the genomic loci were within 3000 base pairs downstream of the 
transcription start site. Of the genomic loci, 20.4% were in the 
5′-untranslated region (5′UTR) of target genes and 1.1% were in the 
3′UTR. Genomic loci in exonic regions accounted for 5.3%, and 
17.8% of the loci were in intronic regions. Distal intergenic regions 
accounted for 16.6% of the ChIP-seq genomic loci (Figure 3A).
Recently it was shown using ChIP-reChIP that B-Myb and 
FOXM1 cooccupy the promoters of genes involved in mitosis 
(PLK1, CCNB1, and AURKA; Sadasivam et al., 2012). Similar results 
were found using ChIP-reChIP of LIN9 followed by FOXM1. We 
compared our FOXM1 ChIP-seq results with the ChIP-seq results of 
not repeat in the second cell cycle (Whitfield et al., 2002). These 
genes are likely induced by the synchronization procedure. To filter 
out these probes, we calculated an autocorrelation score for each 
gene in each time course. The autocorrelation determines whether 
the gene expression ratio at a given time is a good predictor of the 
ratio one cell cycle later. Therefore genes that oscillate and thus 
repeat their expression values over multiple cell cycles receive high 
autocorrelations, whereas genes that do not oscillate receive low or 
negative autocorrelations. Altogether, 690 probes with negative au-
tocorrelations were removed, leaving 2878 probes.
As a final filtering step, we removed 48 probes that showed sys-
tematic bias associated with date of hybridization. These probes 
had no clear periodic expression and are almost certainly systematic 
artifacts from microarray hybridization. To objectively remove genes 
with “date-biased” expression patterns, we projected the spectrum 
for each of the 2878 probes onto the first two principal components 
and organized by k-means clustering. Forty-eight probes that dis-
played expression patterns that correlated with date of hybridiza-
tion clustered together (Supplemental Figure S2A). Those 48 probes 
that grouped together with alternating high and low expression lev-
els, correlated with the hybridization batch (Supplemental Figure 
S2, A and B), were removed, leaving 2830 cell cycle–regulated 
probes corresponding to 2140 Entrez GeneIDs, with 1871 of these 
being unique (Supplemental Table S2).
Overview of periodic gene expression in U2OS cells
To display the selected genes in the order of their timing of peak 
expression within the cell division cycle, we organized genes by 
their phase of peak expression determined by Fourier analysis 
(Figure 2A). The alternating pattern of high and low gene expres-
sion levels shows persistent waves of gene expression across multi-
ple synchronous cell cycles. The phase of peak expression of each 
gene was assigned based on peak correlation to the idealized phase 
expression profiles shown in Figure 1. This method assigns the 
probes to G1/S (1018 probes; 702 unique genes), S phase (546 
probes; 355 unique genes), G2 phase (390 probes; 278 unique 
genes), G2/M (598 probes; 392 unique genes), and M/G1 (278 
probes; 144 unique genes; Figure 2A).
The expression program in U2OS cells has two distinct waves of 
expression—one that occurs in G1 and S phases, and a second that 
occurs in G2 and M phases. We displayed the distribution of genes 
in the two phases by clustering the correlation values for each gene 
to the five idealized expression vectors (Supplemental Figure S3). 
Genes assigned to G1/S or S phase had similar correlation scores to 
the idealized G1/S and S-phase vectors, whereas genes that were 
classified as G2, G2/M, or M/G1 had high correlations to the G2 and 
G2/M vectors. Considerable overlap is observed among genes of 
the G1/S and S-phase transition and between the genes of the 
G2 and G2/M transition. Thus the boundaries between G1/S and 
S phase and between G2 and M phase are necessarily somewhat 
arbitrary, as genes assigned to G1/S can be immediately adjacent to 
genes assigned to S phase. In contrast, there is a distinct break be-
tween the G1- and S-phase genes and the G2- and M-phase genes. 
We analyzed the same distributions in HeLa cells, where we did not 
observe a distinct break between the two waves of expression (Sup-
plemental Figure S3). This suggests that the distinct break observed 
here may be specific to U2OS cells and reflect specific mutations or 
biological changes in this cell line.
To organize the genes in an unbiased manner, we hierarchically 
clustered all cell cycle–regulated probes (Eisen et al., 1998). The 
Database for Annotation Visualization and Integrated Discovery 
(DAVID; Dennis et al., 2003) was used to identify enriched cellular 
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B-Myb and LIN9 but not FOXM1), the most enriched biological 
process was actin cytoskeleton organization (p = 8.18 × 10−05). The 
list of FOXM1 target genes only was enriched for the biological 
process of translation (p = 3.49 × 10−46) and translation elongation 
(p = 1.32 × 10−27; Figure 3B).
We display the expression of genes bound by FOXM1 in our 
ChIP-seq that were also cell cycle regulated (Figure 4), as well as 
those that were not cell cycle regulated (Supplemental Figure S4). 
Sadasivam et al. (2012; Figure 3B). The gene targets found in all 
three ChIP-seq experiments were enriched for genes involved in 
mitosis (DAVID, M phase, p = 3.26 × 10−39). There was also enrich-
ment for cell cycle–related processes for the FOXM1/B-Myb over-
lap (Figure 3B; cell cycle, p = 5.35 × 10−06) as well as for the FOXM1/
LIN9 overlap (cell division, p = 6.36 × 10−05). Of interest, after re-
moval of the FOXM1 target genes from the B-Myb/LIN9 target list 
(i.e., target genes of all three transcription factors vs. targets of 
FIGURE 2: Periodically expressed genes in the U2OS cell cycle. (A) The 2830 probes that show periodic expression in 
U2OS cells, ordered by the point of their peak expression as calculated from their sine and cosine values in the Fourier 
transform. Phase assignments were performed using the correlation coefficients with the ideal vectors defined in 
Figure 1. The color bar on the right indicates the phase of peak expression (G1/S, green; S, blue; G2, red; G2/M, yellow; 
and M/G1, black); blended colors indicate interspersed phase assignments. (B) The 2830 periodically expressed probes 
from U2OS cells were ordered by average linkage hierarchical clustering. The enriched biological processes of select 
clusters is indicated.
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FIGURE 3: FOXM1 ChIP-seq indicates a role for FOXM1 in the cell cycle and translation. (A) CEAS analysis of the 
overlapping FOXM1 ChIP-seq analysis shows enrichment in promoters, downstream regions, 5′UTRs, and coding exons 
relative to background. (B) Venn diagram showing the overlapping gene targets of FOXM1, B-Myb, and LIN9 (b-Myb 
and LIN9 results from Sadasivam et al., 2012). There is enrichment in cell cycle Gene Ontology (GO) terms for biological 
process (BP) and cellular component (CC) in the overlapping gene lists for FOXM1/B-Myb, FOXM1/B-Myb/LIN9, and 
FOXM1/LIN9. FOXM1 genes that do not overlap with B-Myb or LIN9 show an enrichment in the GO term translation. 
(C) Bar graph showing the percentage of FOXM1 targets per cell cycle phase. (D) Bar graph showing the percentage of 
genes in each phase that are bound by FOXM1.
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To represent FOXM1 binding relative to 
gene models, we show the percentage cov-
erage of different regions of each gene 
model as defined by GCA (Supplemental 
Figure S6). We then linked the genes for 
each FOXM1 ChIP-seq loci via Entrez Gene-
IDs to genes that are cell cycle regulated in 
U2OS cells. Of the 1871 unique cell cycle–
regulated genes in U2OS cells, 287 showed 
evidence of FOXM1 occupancy at their pro-
moters. Because FOXM1 is known to drive 
the expression of G2/M phase genes, we 
first examined the expression of known 
G2/M FOXM1 targets, AURKB, CCNB1, 
CCNB2, PLK1, and TOP2A, which all had 
FOXM1 bound in their promoters (Supple-
mental Figure S5). Of the 278 genes ex-
pressed in G2, 98 (35.2%, p < 0.001) were 
bound by FOXM1 in our ChIP-seq data. Of 
the 392 genes expressed in G2/M, 102 
(26%, p < 0.001) were bound by FOXM1. 
Progressing through the cell cycle, there 
were 16 M/G1 genes bound by FOXM1 out 
of 144 (11.1%; not significantly enriched 
[NS]). Surprisingly, we found a number of 
G1- and S-phase genes that were bound by 
FOXM1, including TYMS, RMI1, and replica-
tion-dependent histone genes. FOXM1 
binds to 6.1% of the genes expressed in 
G1/S (43 of 702; NS) and 7.8% of S-phase 
genes (28 of 355; NS).
Many FOXM1 target genes in different 
cell types have been reported (reviewed in 
Wierstra and Alves, 2007). Given that 
FOXM1 has roles in cell cycle progression, 
metastasis (through MMP2 and MMP9; 
Wang et al., 2008), and development in 
many cell types, we focused on FOXM1 tar-
gets in cell types that display epithelial mor-
phology. In our ChIP-seq analysis we identi-
fied the promoters of all four previously 
published FOXM1 targets in HeLa cells 
(AURKA, PLK1, CCNB1, and RACGAP1; 
Sadasivam et al., 2012). Looking at genes 
previously shown to be bound by FOXM1 
by ChIP in U2OS cells, we found five of nine 
published FOXM1 targets (Dai et al., 2007; 
Wang et al., 2007; Chen et al., 2009; Chetty 
et al., 2009; Ahmed et al., 2012).
Of the previously reported G2- or M-
phase FOXM1 target genes that were also 
cell cycle regulated in HeLa cells, 32 of 39 
(∼82%) were found in our analysis of U2OS 
cells, whereas only five of 16 (∼31%) of the 
published FOXM1 targets expressed in G1 
or S phases were identified in our analysis in 
U20S cells (Supplemental Figure S6 and 
Supplemental Table S4). Most FOXM1 ChIP-
seq target genes were cell cycle regulated 
in U2OS cells (27 of the top 30) and HeLa 
cells (28 of the top 30; Whitfield et al., 2002). 
FIGURE 4: The expression profiles of genes bound by FOXM1. The clustered U2OS and HeLa 
cell expression profiles of the 501 genes bound by FOXM1 that are cell cycle regulated in U2OS 
cells. FOXM1 transcription factor binding is shown as percentage coverage of the UCSC 
genome browser gene model as defined by GCA for each gene (see Supplemental Figure S6 for 
more detail).
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Histone genes clustered together in a tight group likely due to 
their unique mechanism of regulation, which is primarily by post-
transcriptional mechanisms controlled by histone SLBP (Wang et al., 
1996; Whitfield et al., 2000). Consistent with this, only two of the 
genes in this cluster are bound by E2F1, but, surprisingly, 53% of the 
histone genes are bound by E2F4 (9 of 17 genes in the cluster) and 
47% by FOXM1 (8 of 17). Given that E2F4 is known to repress 
S-phase genes in G0, it may play a similar role for the histone genes, 
whose expression is tightly restricted to S phase. Of these genes, 
18% (3 of 17) were bound by FOXK1, recently shown to be involved 
in G1/S-phase gene activation (Figure 6B).
The mitosis cluster contains genes involved in the processes of 
DNA segregation and chromosome organization (KIF11, KIF2C, and 
KIF4A) and regulation of mitosis (PLK1, CCNB1, CCNB2, BUB1, 
STK6 [AURKA], CCNA2, CCNF, and CDC25C). Of the mitotic genes, 
58% (68 of 118, p < 0.001) are bound by E2F4, likely as a compo-
nent of the repressive DREAM complex; 76% (90 of 118, p < 0.001) 
are bound by FOXM1, and only 24% (28 of 118, NS) are bound by 
E2F1. Eleven percent (13 of 118, NS) are bound by E2F6 and 3% 
(4 of 118, NS) by FOXK1. GABPA binds to 35% (41 of 118, p < 
0.001), albeit at a lower percentage of promoter coverage than 
FOXM1 or E2F4 (Figure 6C). Of the genes found in this cluster, 37% 
(44 of 118) are also cell cycle regulated in HeLa cells, corresponding 
to the “spindle assembly” and “mitotic surveillance” clusters 
(Whitfield et al., 2002).
Transcription factor binding by cell cycle phase
Transcription factor binding across the cell cycle was displayed as a 
function of the significance of enrichment (Fisher’s exact test) of a 
transcription factor–binding site over a sliding window of phase-or-
dered genes (Figure 7A). This demonstrates that E2F1 binding 
shows significant enrichment in late G1/S phase of the cell cycle, 
whereas FOXM1 binding is significantly enriched at G2/M phase of 
the cell cycle. As expected, both show low enrichment of binding in 
the opposite phase. E2F4 shows biphasic binding, with enrichment 
in G1/S and G2/M phases. We also examined gene density by cell 
cycle phase and found that the regions with peak binding of these 
three transcription factors correspond to the highest gene density 
(Figure 7B).
To determine the specific cell cycle phase in which each tran-
scription factor is enriched, we calculated enrichment using the 
phase assignments for each gene that we assigned using our ideal-
ized vectors (Figure 7C and Table 2). We find that E2F1 binding is 
significantly enriched in G1/S (p = 1.20 × 10−6). E2F enrichment is 
not significant in other cell cycle phases but is bound to 47% (16 of 
34) of S-phase genes, 26% (16 of 60) of G2 genes, 27% (20 of 74) of 
G2/M genes, and 10% (2 of 20) M/G1 genes. E2F4 shows biphasic 
enrichment, with significant interactions with genes that peak at 
G1/S (p = 1.43 × 10−5), as well as with those that show peak expres-
sion at G2/M phase (p = 8.79 × 10−33; Table 2 and Figure 7C). E2F4 
is bound to ∼53% (35 of 65) of G1/S, ∼44% (15 of 34) of S phase, and 
∼28 (17 of 60) of G2 genes and ∼48% (36 of 74) G2/M phase targets. 
FOXM1-binding sites show significant enrichment for genes that 
peak in G2 (p = 1.09 × 10−40), G2/M (p = 8.79 × 10−33), and M/G1 
(p = 5.4 × 10−4). FOXM1 is bound to a 73% (44 of 60) of G2 genes 
and 70% (52 of 74) of G2/M-phase genes but only ∼15% (10 of 65) 
of G1/S and ∼20% (7 of 34) of S-phase genes. E2F6 showed only 
weak enrichment for G1/S (p = 0.0010 and 0.0018) and only when 
using binding sites defined in K562 or K562b cells (Table 2 and 
Figure 7C). These data demonstrate a complex interplay of regula-
tion between G1/S- and G2/M-phase transcription factors, which 
includes a biphasic binding by E2F4.
Of the 12 published FOXM1 target genes not found in our ChIP-seq 
data, only three were cell cycle regulated: CDC25A in U2OS and 
HeLa, BRCA2 in U2OS only, and SKP2 in HeLa only (Supplemental 
Figure S7).
To determine whether FOXM1 can induce luciferase expression 
from promoters found in our ChIP-seq data, we used the LumiCycle, 
a luminometer that measures luciferase expression from live cells in 
real time (Grant et al., 2012). We cotransfected U2OS cells with ei-
ther a Flag-tagged FOXM1C construct or the empty vector (pBABE-
puro) and a promoter luciferase target. We tested the ability of 
FOXM1 to activate seven genes found among our ChIP-seq data. 
These included the well-characterized FOXM1 targets CENPE, 
PLK1, and TOP2A genes, with peak expression in G2 or G2/M 
phase. We also tested a subset of the novel FOXM1 targets identi-
fied in our screen: MCM8, RPS6KB1, and RMI1. As a negative con-
trol, we used the FOXK1 target ACAP3 (Grant et al., 2012), which 
contains a forkhead box cis-element but is not bound by FOXM1, as 
determined by our ChIP-seq analysis. As expected, the ACAP3 pro-
moter showed no induction after transfection with FOXM1, whereas 
all other promoters were activated by exogenous FOXM1C expres-
sion (Figure 5). Given that both MCM8 and RMI1 are expressed in 
S phase, this demonstrates that FOXM1C can activate expression of 
S-phase genes, albeit at a lower level of induction. RPS6KB1 is not 
cell cycle regulated in HeLa cells but is in U2OS cells and can be 
overexpressed in cancers (Sinclair et al., 2003; Yamnik et al., 2009). 
RPS6KB1, a downstream target of mammalian target of rapamycin 
(mTOR), plays multiple roles in translation, including phosphoryla-
tion of eIF-4B, as well as phosphorylation of the negative regulator 
of eIF4A, PDCD4, targeting PDCD4 for destruction (reviewed in 
Fenton and Gout, 2011).
Transcriptional regulators of the cell cycle gene expression 
program
To identify the transcriptional regulators of the genome-wide cell 
cycle gene expression program, we obtained ChIP-seq data from 
the ENCODE project for transcription factors E2F1, E2F4, E2F6, and 
GA-binding protein transcription factor, α subunit 60 kDa (GABPA 
[GABP]), each implicated in cell cycle control. We reanalyzed the 
data to identify ChIP-seq loci using MACS and associated loci with 
gene regions. We also included ChIP-seq data for FOXM1 and 
FOXK1 (Grant et al., 2012). Cell cycle gene expression data were 
collapsed to Entrez GeneIDs and merged with the Entrez GeneID–
associated ChIP-seq loci. Gene expression and ChIP-seq data were 
coclustered and in the following are discussed in detail by biological 
process.
The DNA replication cluster includes genes involved in the pro-
cess of DNA synthesis, including components of the prereplication 
complex (MCM2, 3, 4, and 6), nucleotide biosynthesis (RRM2), 
DNA replication (PCNA, CLSPN, EXO1, POLD3, RFC4, and DCC1), 
and DNA packaging (CHAF1A, CHAF1B, and SLBP). We also find 
genes involved in S-phase regulation (E2F1, CDC6, CDC25A, 
CCNE1, and RBBP8) and DNA repair (UNG, BARD1, BRIP1, and 
RAD51). The G1/S-phase transcriptional regulator E2F1 is bound 
to 67% (68 of 101) of the unique genes in this DNA replication 
cluster. E2F4, which is a member of the DREAM complex that re-
presses the expression of S-phase genes during G0 (Litovchick 
et al., 2007), is bound to 60% of the genes in this cluster (61 of 
101). Greater than half (56) of the genes in this cluster have both 
E2F1 and E2F4 bound (Figure 6A). Comparison with cell cycle–
regulated genes in HeLa cells (Whitfield et al., 2002) shows that 
42% (39 of 93) of those bound by E2F1 or E2F4 were regulated 
there.
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FIGURE 5: FOXM1 overexpression activates the expression of a number of target genes found via ChIP-seq. (A) Neither 
FOXM1 (light line) nor the empty vector control (dark line) activates the ACAP3 promoter. ACAP3 is a known FOXK1 
target (Grant et al., 2012) and is used as a negative control. (B–D) FOXM1 activates the promoters of PLK1, CENPE, and 
TOP2A, known FOXM1 targets (Figure 4 and Supplemental Figure S6). (E) FOXM1 activates the MCM8 promoter. 
(F) FOXM1 activates the promoter of RPS6KB1, which phosphorylates the 6S ribosomal protein. (G) The previously 
unknown FOXM1 target RMI1 promoter is activated by FOXM1 overexpression. Error bars, SEM. Time points were 
binned and averaged for every 24 h for a one-way analysis of variance. *p ≤ 0.05; **p ≤ 0.01, ***p ≤ 0.005.
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assigned to a cell cycle phase: 56% had peak expression in G1 or S 
phase, whereas 35.8% had peak expression in G2 or M phase.
Comparison to other cell cycle expression data sets 
in mammalian cells
There have been a number of reports on the periodic expression of 
cell cycle genes in mammalian cells. These reports often used differ-
ent cell lines/types, as well as different analysis methods. We focus 
on three studies that use human cells and either a double-thymidine 
or thymidine–nocodazole block.
Whitfield et al. (2002) published the cell cycle–regulated genes 
in HeLa cells. They reported 651 unique genes that were cell 
cycle regulated. Here we report 1871 unique genes that are cell 
cycle regulated in U2OS cells. Of these genes, 253 (38.8%) are 
cell cycle regulated in both cell lines when analyzed using the 
same analysis pipeline.
Genes cell cycle regulated in both studies include well-known 
genes that have peak expression in G1/S phase, such as E2F1, 
BARD1, CHAF1A, CHAF1B, as well as CCNE1 and CCNE2. This 
also holds true for genes involved in DNA replication with peak ex-
pression in S phase, including RRM2, PRIM1, RBBP8, and RFC2. 
U2OS genes peaking in mitosis have good overlap with mitosis 
Identification of a common set of cell cycle–regulated genes
To identify the common cell cycle genes regulated across multiple 
cell types, we merged and compared the U2OS, HeLa, and EN-
CODE data (Figure 8). We compared the 1871 unique genes cell 
cycle regulated in U2OS cells to the 651 unique cell cycle-regulated 
genes in HeLa cells. We found that 253 of the 651 (38.8%) HeLa cell 
cycle–regulated genes were also cell cycle regulated in U2OS cells. 
These overlapping genes predominantly consisted of those involved 
in core processes of mitosis and S phase. Many of these genes are 
well known cell cycle genes, such as PLK1, CCNB1, E2F1, and 
CCNE2; however, there were a number of less well-characterized 
genes that are cell cycle regulated in all four cell types, including 
FLJ10156 (FAM64A), ARL6IP, DLG7 (DLGAP5), HMGB3, TROAP, 
SHCBP1, ANP32E, GPR126, HJURP, SLC38A2, and C14orf130 
(UBR7), which may represent less well-studied proteins involved in 
essential biological processes required to duplicate a cell.
DISCUSSION
We identified 1871 unique genes expressed in a cell cycle–depen-
dent manner in the well-studied U2OS cancer cell line. This cell line 
was chosen because it is amenable to multiple synchronization 
methods, with a low percentage of noncycling cells. Each gene was 
FIGURE 6: Biological process–specific gene clusters have coordinated transcription factor binding. (A) After the 
inclusion of FOXM1 ChIP-seq data as well as ENCODE data, hierarchical clustering shows that the genes in the U2OS S 
phase cluster are predominantly bound by E2F1 and E2F4. (B) The histone cluster shows E2F4 bound to more gene 
models than E2F1 or FOXM1. (C) Genes in the mitosis gene cluster are primarily bound by FOXM1 or E2F4. 
Transcription factor binding is shown as percentage of coverage of each portion of the gene model as defined by GCA 
(see Supplemental Figure S6 for more details).
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Although the methods for determining which genes are cell cy-
cle regulated are very similar for both HeLa and U2OS, there are 
experimental differences that may affect the results. These include 
different array platforms and differences in sample preparation, 
sample collection methodologies, and time-point collection. There 
are also differences in the lengths of each time course and how 
many cell cycles were contained in each. HeLa cells have a cell cycle 
genes in HeLa and foreskin fibroblasts, including PLK1, CCNB1, 
CDC25B, CDC25C, CENPA, CENPE, CENPF, and TOP2A. There are 
also overlapping genes that have peak expression during mitosis 
into G1, including CEP70, UBE2D3, BAIAP2, and PDGFA. Thus we 
identified a large number of previously known cell cycle–regulated 
genes, as well as a number of novel cell cycle–regulated genes in 
U2OS cells.
FIGURE 7: Transcription factor binding as a function of cell cycle phase. (A) Enrichment of transcription factor targets 
using a sliding window across the cell cycle indicates enrichment of E2F1, E2F4, and FOXM1 binding to genes that show 
peak expression at specific times during the cell cycle. Phase angles were calculated from the arc tangent of the Fourier 
analysis. Transcription factor binding enrichment was calculated using Fischer’s exact test over a sliding window of 30° 
with a 10° overlap between neighboring windows. Cell cycle phase is indicated (B) Gene density in each sliding window 
was calculated for the expression of all the cell cycle–regulated genes in U2OS cells. (C) Enrichment of transcription 
factor targets in each cell cycle phase was calculated using estimated phase boundaries rather than a sliding window. 
The significance of transcription factor binding enrichment was calculated using Fischer’s exact test. Transcription factor 
binding data were from HeLa cells, except for E2F6, which was from K562 cells. The p values for each transcription 
factor at each phase are given in Table 2.
Transcription 
factor G1/S S G2 G2/M M/G1 Minimum p
Minimum 
p phase
E2F1 (HeLa) 1.20E-06 0.16 0.70 0.41 1.00 1.20E-06 G1/S
E2F6 (K562) 0.0010 0.20 0.59 1.00 0.36 0.0010 G1/S
E2F6 (K562b) 0.0018 0.18 0.91 1.00 0.12 0.0018 G1/S
E2F6 (HeLa) 0.29 0.42 1.00 0.69 0.46 0.29 G1/S
FOXM1 0.79 0.53 1.09E-40 8.79E-33 0.00054 1.09E-40 G2
E2F4 (HeLa) 1.43E-05 0.05 9.71E-16 5.51E-09 0.66 9.71E-16 G2
E2F4 (K562b) 9.73E-07 0.00076 2.78E-10 1.56E-07 0.66 2.78E-10 G2
TABLE 2: Enrichment of transcription factor–binding loci by cell cycle phase.
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FIGURE 8: Core cell cycle–regulated genes between HeLa cells and U2OS cells are bound by FOXM1 or E2F1. The 253 
genes that show periodic regulation in both HeLa cells and U2OS cells have been clustered after the inclusion of the 
FOXM1 and FOXK1 ChIP-seq data and the ENCODE data for selected transcription factors. Transcription factor binding 
is shown as percentage of coverage of each portion of the gene model as defined by GCA (see Supplemental Figure S6 
for more details).
length of ∼14–15 h, so a 48-h time course can contain three com-
plete cell cycles. The cell cycle length of U2OS cells is ∼18–20 h, and 
so a 48-h time course would be expected to have only ∼2.5 cell 
cycles.
Bar-Joseph et al. (2008) published the cell cycle–regulated genes 
in normal foreskin fibroblasts. We compared the U2OS data set to 
the cell cycle–regulated genes in their experiments (Bar-Joseph 
et al., 2008). Of the 480 genes identified as cell cycle regulated in 
foreskin fibroblasts, 228 (47.5%) were also regulated in U2OS cells. 
Like the U2OS data set, the samples in the foreskin fibroblast data 
set were collected every 2 h and arrayed on commercially available 
arrays (Affymetrix U133A 2.0 arrays; Bar-Joseph et al., 2008). Thus 
there are a number of potential reasons for the amount of overlap 
between the U2OS and the foreskin fibroblast data sets: cell type, 
transformed versus normal cells, arrays, and analysis methods.
This compares similarly to the analysis in Bar-Joseph et al. (2008), 
in which there was ∼40% overlap between the genes identified as 
regulated in HeLa cells and those cell cycle regulated in foreskin fi-
broblasts. Reanalysis of the HeLa data set with their analysis method 
shows that 362 of 481 genes (75.3%) overlapped (Bar-Joseph et al., 
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Recently it was shown that FOXM1 binds to G2/M-phase gene 
promoters via CHR elements (Chen et al., 2013), which are also 
important to both DREAM and B-Myb-MuvB complex binding 
(Sadasivam et al., 2012). Similar to the results published here 
(Figure 3B), Chen et al. (2013) show that FOXM1 binds to many of 
the same promoters as LIN9 and B-MYB and that both FOXM1 
ChIP-seq data sets are enriched for genes involved in mitosis. How-
ever, due to experimental differences, the data set presented here 
is also enriched for genes involved in translation that are not cell 
cycle regulated. Our data support the possibility that FOXM1 is 
weakly bound to a subset of genes expressed during S phase 
(Figures 6, A and B, and 7).
The genes cell cycle regulated in both HeLa and U2OS cells are 
generally bound by at least one of the cell cycle transcription factors. 
Of the 253 genes that are cell cycle regulated in U2OS and HeLa 
cells, 183 (∼72%) of the promoters are bound by at least one tran-
scription factor, 70 (∼28%) of the promoters are bound by two tran-
scription factors, and 63 (∼25%) of the promoters are bound by three 
or more. Thus each cell cycle gene may be regulated by the combi-
natorial effects of multiple cell cycle transcriptional factors. This 
would allow for very precise temporal regulation of cell cycle genes, 
as well as provide a high degree of redundancy in the system.
These data provide a catalogue of the cell cycle–regulated genes 
in U2OS cells and, along with associated transcription factor binding 
data, are available to anyone for any purpose. This will provide a 
resource for the scientific community, and the full data set is avail-
able from Gene Expression Omnibus (www.ncbi.nlm.nih.gov/geo/
query/acc.cgiat) at accession number GSE52100.
MATERIALS AND METhODS
Cell culture, synchronization, and RNA preparation
HeLa and U2OS cells were passaged in a 37°C humidified incubator 
in DMEM with 10% fetal bovine serum and 100 U of penicillin–strep-
tomycin following standard protocols.
U2OS cells were synchronized using a double-thymidine proto-
col or a thymidine–nocodazole protocol. Briefly, 3.0 × 105 cells were 
plated in 16 ml of DMEM. After 24 h of growth, thymidine was 
added to a final concentration of 2.5 mM. After 18 h in thymidine 
media cells were washed twice with prewarmed CO2-equilibrated 
phosphate-buffered saline (PBS) and allowed to grow for 8 h in pre-
warmed CO2 equilibrated DMEM. Again thymidine was added to a 
final concentration of 2.5 mM for another 18 h. Cells were washed 
twice with PBS and released into DMEM. For the thymidine–
nocodazole synchronization, U2OS cells were plated (5.0 × 105 cells) 
and allowed to grow for 24 h. Thymidine (2.5 mM) was added 
for 18 h before cells were washed twice with prewarmed CO2-
equilibrated PBS before treatment with DMEM supplemented with 
100 ng/ml nocodazole for 12 h. Floating cells were collected and 
spun down, washed twice with prewarmed CO2-equilibrated PBS, 
and resuspended in prewarmed CO2-equilibrated DMEM. Non-
floating cells were washed twice with prewarmed CO2-equilibrated 
PBS and released into prewarmed CO2-equilibrated DMEM, and 
the resuspended floating cells were added back to each plate. Cells 
were collected every 2 h for a minimum of 36 h using RNeasy Plus 
Mini Kit (Qiagen, Valencia, CA). Zero-hour samples were collected 
while cells were still in arrest conditions.
Synchrony was monitored via fluorescence-activated cell sorting 
(FACS) analysis of propidium iodide–labeled cells (DartLab, Geisel 
School of Medicine at Dartmouth College) and FOXM1 phosphory-
lation state or cyclin B1 expression via Western blots (see later de-
scription). Samples were collected for Western blot analysis using 
SDS–PAGE sample buffer.
2008). Overlap of the genes identified as cell cycle regulated 
in U2OS, HeLa (Whitfield et al., 2002), and foreskin fibroblasts 
(Bar-Joseph et al., 2008) shows 142 cell cycle–regulated genes in all 
three cell types (Supplemental Table S3).
Despite the pairwise overlaps being in the 40% range, there are 
142 genes that are cell cycle regulated in all three cell types. Many 
of these are involved in the core processes of either DNA replica-
tion or mitosis, which are tightly regulated and involve a discrete 
set of genes. These overlapping genes may be “core cell cycle” 
regulators that are critical for all cell types. Recently Pena-Diaz et al. 
(2013) reported the cell cycle–regulated genes in HaCaT human 
keratinocytes. They found that of 1249 Entrez genes cell cycle reg-
ulated in this cell line, 125 genes also were cell cycle regulated in 
HeLa and foreskin fibroblasts. This is similar to the number we re-
port (142 genes) as cell cycle regulated in three different cell types. 
The inclusion of HaCat cells in our comparison of all cell types re-
duces the number of common periodic genes to 96 (Supplemental 
Figure S8 and Supplemental Table S3). These 96 genes represent 
genes involved in core cell cycle processes.
Many of the cell cycle–regulated genes in all three cell types 
have either E2F1 or FOXM1 bound at their promoters. This implies 
that these two transcription factors are responsible for the highly 
periodic expression patterns seen in either S phase (E2F1) or G2/M 
(FOXM1). Unfortunately, E2F1 does not bind the promoter of 
FOXM1, nor does FOXM1 bind the promoter of E2F1, so it appears 
that E2F1 does not directly induce FOXM1. This would imply that 
there is not a continuous transcription factor–based circuit that regu-
lates the cell cycle; instead, there is an interplay of transcriptional 
activation, phosphorylation, degradation, and sequestration (among 
other methods) that controls cell cycle regulation.
It is becoming apparent that there may be cell type–depen-
dent, cell cycle–regulated genes. As cell cycle–regulated genes are 
catalogued for different cell lines (or types), it will be interesting 
to determine which genes are cell line dependent and which 
genes are cell type dependent, and to determine with more 
precision which genes are invariant across all cycling cells. These 
results suggest that it may be informative to determine the differ-
ences in cell cycle gene expression between different cell types/
lines of the same lineage, embryonic stem cells, or induced pluri-
potent stem cells to begin to determine the changes through 
developmental lineages.
Regulation of the cell cycle gene expression program
Previous reports showed that FOXM1 is required for proper pro-
gression through mitosis due to a requirement for the FOXM1 acti-
vation of critical mitosis genes (e.g., PLK1, CDC25B, and CCNB1; 
Laoukili et al., 2005; Wonsey and Follettie, 2005). Here, via FOXM1 
ChIP-seq, we showed that not only are these genes activated by 
FOXM1, but in addition a number of other genes that are involved 
in proper mitotic progression are also activated by FOXM1. The 
number of genes that are direct FOXM1 targets implies that FOXM1 
is a regulator of G2/M-phase transcription. In addition to binding a 
large number of G2/M-phase genes, FOXM1 binds a large number 
of targets that are involved with translation, a process that is ongo-
ing throughout the cell cycle. Of interest, FOXM1 is not cell cycle 
regulated at the RNA level in U2OS cells, whereas it is regulated in 
HeLa cells. This is possibly due to cell type–specific methods of 
regulation or perhaps to U2OS cells having a relatively intact p53 
pathway whereas HeLa cells do not, due to the presence of HPV E6 
and E7 proteins (Gao et al., 2009). There is 43% overlap between 
the three S-phase clusters in HeLa cells and the S-phase cluster in 
U2OS cells.
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when randomizing by rows only. Inclusion of the Thy-Noc time 
course resulted in improved false-positive and false-negative rates, 
despite having a lower degree of synchrony than the Thy-Thy time 
courses (Supplemental Figure S9)
To account for genes that received a high Fourier score but did 
not have a sinusoidal expression pattern throughout each time 
course, we calculated autocorrelation scores (Whitfield et al., 2002, 
Eq. 5). We calculated and summed the autocorrelation scores for 
each time course, leaving 2878 genes. To remove any genes that 
had an obvious date bias from technical issues during array hybrid-
ization, we found their power spectra using the Fourier transform of 
each time course. The date-biased genes were then removed by 
projecting the power spectra onto their first two principal compo-
nents and clustered by k-means (k = 2; Supplemental Figure S2). 
Removing these genes gave us a final data set of 2830 probes. The 
2830 probes correspond to 2140 Entrez GeneIDs with 1871 unique 
gene identifiers.
ChIP-seq and analysis
FOXM1 ChIP-seq was carried out as previously described (Lupien 
et al., 2008; Grant et al., 2012) using the FOXM1 antibody sc-502 
(C20; Santa Cruz Biotechnology, Santa Cruz, CA). Briefly, asynchro-
nous HeLa cells were fixed using 1% formaldehyde before sonica-
tion to produce DNA fragment lengths of 200–600 base pairs with 
a Bioruptor (Diagenode, Sparta, NJ). Anti-FOXM1 was bound to a 
mix of Protein A and Protein G Dynabeads (Life Technologies, 
Grand Island, NY) before an 18-h incubation at 4°C with the frag-
mented DNA. Bound DNA was washed and the cross-links re-
versed before DNA purification with a QIAquick PCR purification 
kit (Qiagen). DNA concentrations were measured using Quant-iT 
PicoGreen (Life Technologies). Library construction and sequenc-
ing for each ChIP-seq run were carried out independently at the 
High Throughput Sequencing Facility at the University of North 
Carolina (Chapel Hill, NC) using an Illumina Genome Analyzer II. 
Fastq files were mapped to the human genome using Bowtie 
(version 0.12) using the “best” flag to constrain alignments to 
those with the best read quality and fewest mismatches. The first 
ChIP-seq run resulted in 17.1 million sequence reads (8.4 mapped 
sequence reads), and the second ChIP-seq run resulted in 
17.0 million reads (8.4 million mapped reads; human genome 
build Hg18). Enriched peaks were determined independently for 
each run using MACS, version 1.3 (run 1, mfold 32, p < 1.0 × 10−5; 
run 2, mfold 25, p < 1.0 × 10−5; Zhang et al., 2008). This resulted in 
5727 peaks for the first run and 2849 peaks for the second. As a 
conservative estimate of FOXM1 binding, we analyzed the inter-
section of the sequences under the peaks that were found in both 
ChIP-seq runs, resulting in 2215 shared FOXM1 genomic loci. We 
then determined the distribution of the shared FOXM1 genomic 
loci using the cis-Regulatory Element Annotation System (CEAS; 
http://liulab.dfci.harvard.edu/CEAS/; Zhang et al., 2008; Shin 
et al., 2009) implemented in Cistrome (www.cistrome.com/). Raw 
ChIP-seq data and BED files are available from GEO at accession 
number GSE52098 (part of SuperSeries GSE52100).
Real-time luciferase assays
U2OS cells were plated at ∼20–25% density in 30-mm dishes and 
allowed to grow for 24 h. After 24 h, the growth medium was re-
placed with assay medium (Phenol red–free L15 [Life Technologies], 
10% fetal bovine serum, 1% penicillin/streptomycin, 10 mM 
4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid buffer, and 
0.1 mM luciferin). Cells were then transfected with equal amounts of 
plasmid (typically 250 ng of each plasmid) using FuGENE 6 (Life 
Reference RNA was isolated from asynchronously growing U2OS 
cells using an RNeasy Plus Mini Kit. The same reference was used for 
all hybridization experiments.
Microarray hybridization and analysis
Microarrays were run as described previously (Grant et al., 2012). 
Briefly, cellular RNA was amplified and Cy3 (asynchronous U2OS 
RNA) or Cy5 (sample) labeled using the Quick-Amp Labeling kit 
(Agilent Technologies, Santa Clara, CA) following the manufacturer’s 
protocol, except that the reaction volumes were reduced by one-
half. Labeled cRNA was hybridized to Agilent Whole Human Ge-
nome Oligonucleotide arrays (4 × 44k) following the manufacturer’s 
protocol. Microarrays were scanned using a GenePix 4000B scanner 
(Molecular Devices, Sunnyvale, CA). Spot pixel intensities were de-
termined using GenePix Pro 5.1 software. Poor-quality spots were 
identified and flagged by hand and excluded from subsequent anal-
ysis. Arrays were stored in the University of North Carolina Microar-
ray Database (Chapel Hill, NC; UMD). The full raw microarray data 
are available from the GEO at accession number GSE50988 (part of 
SuperSeries GSE52100).
Each time course was retrieved from the UMD independently 
from each other time course with the following conditions. Only 
spots with ratio of intensity over background of >1.5 were used. 
Genes missing >30% of their data were excluded from further analy-
sis. Genes were normalized using Lowess normalization.
Identification of periodically expressed transcripts
Periodically expressed transcripts were identified using the same 
method as in Whitfield et al. (2002). Briefly, missing data were im-
puted using a k-nearest neighbors algorithm (Troyanskaya et al., 
2001) using k = 12. Then each time course was centered by remov-
ing the first eigengene (Alter et al., 2000). Imputed data were re-
moved from the data set as the last step of the analysis.
Rough estimates of the U2OS cell cycle were initially obtained 
from Western blot analysis of cell cycle–regulated phosphorylation 
of FOXM1 and FACS analysis for each time course. This estimate 
was then refined by performing a Fourier transform on each gene in 
each time course (Whitfield et al., 2002, Eqs. 1–3) with equally 
spaced values of time (every 15 min) for the estimated cell cycle 
length ±two hours.
An offset (φ; Whitfield et al., 2002, Eqs. 1 and 2) was determined 
for each time course relative to the first time course. The Fourier 
transform was then repeated for each time course using the following 
values of T and φ: Thy-Thy 1 (T = 17.65, φ = 0.0), Thy-Thy 2 (T = 18.6, 
φ = 0.0), Thy-Thy 3 (T = 18, φ = 0.0), and Thy-Noc (T = 23.95, φ = 2.3). 
The vectors for each data set were then summed and genes ranked 
by the magnitude of their combined vectors (C). To compensate for 
the imperfect match to sine or cosine curves, each gene was scaled 
by its correlation to an idealized vector. The ideal vector for each cell 
cycle phase (G1/S, S, G2, G2/M, and M/G1) was defined by the aver-
age expression profiles of the indicated genes in Figure 1. Using a 
standard Pearson correlation, each gene received a peak correlation 
score, which was its largest absolute value correlation with each of 
the ideal vectors. This peak correlation score was then used to scale 
each gene’s C, generating a periodicity score for each gene.
Randomized data were then used to set a cutoff value for the 
minimum periodicity score to be considered cell cycle regulated. 
The data were randomized 10 times either within rows only or in 
rows and columns. The full analysis pipeline was performed for each 
of these randomizations using the same parameters as for the un-
randomized data. We chose a minimum periodicity score of 2.65, 
which gave us 3568 genes with an initial false-positive rate of 3.67% 
3648 | G. D. Grant et al. Molecular Biology of the Cell
Ahmed M et al. (2012). FoxM1 and its association with matrix metallopro-
teinases (MMP) signaling pathway in papillary thyroid carcinoma. J Clin 
Endocrinol Metab 97, E1–E13.
Alter O, Brown PO, Botstein D (2000). Singular value decomposition for 
genome-wide expression data processing and modeling. Proc Natl 
Acad Sci USA 97, 10101–10106.
Alvarez-Fernandez M, Halim VA, Krenning L, Aprelia M, Mohammed S, 
Heck AJ, Medema RH (2010). Recovery from a DNA-damage-induced 
G2 arrest requires Cdk-dependent activation of FoxM1. EMBO Rep 11, 
452–458.
Alvarez-Fernandez M, Medema RH (2013). Novel functions of FoxM1: from 
molecular mechanisms to cancer therapy. Front Oncol 3, 30.
Bar-Joseph Z, Siegfried Z, Brandeis M, Brors B, Lu Y, Eils R, Dynlacht BD, 
Simon I (2008). Genome-wide transcriptional analysis of the human cell 
cycle identifies genes differentially regulated in normal and cancer cells. 
Proc Natl Acad Sci USA 105, 955–960.
Bergamaschi A, Christensen BL, Katzenellenbogen BS (2011). Reversal of 
endocrine resistance in breast cancer: interrelationships among 14-3-
3zeta, FOXM1, and a gene signature associated with mitosis. Breast 
Cancer Res 13, R70.
Bonet C, Giuliano S, Ohanna M, Bille K, Allegra M, Lacour JP, Bahadoran 
P, Rocchi S, Ballotti R, Bertolotto C (2012). Aurora B Is regulated by the 
mitogen-activated protein kinase/extracellular signal-regulated kinase 
(MAPK/ERK) signaling pathway and is a valuable potential target in 
melanoma cells. J Biol Chem 287, 29887–29898.
Calvisi DF et al. (2009). Forkhead box M1B is a determinant of rat suscepti-
bility to hepatocarcinogenesis and sustains ERK activity in human HCC. 
Gut 58, 679–687.
Chen CH, Chien CY, Huang CC, Hwang CF, Chuang HC, Fang FM, Huang 
HY, Chen CM, Liu HL, Huang CY (2009). Expression of FLJ10540 is cor-
related with aggressiveness of oral cavity squamous cell carcinoma by 
stimulating cell migration and invasion through increased FOXM1 and 
MMP-2 activity. Oncogene 28, 2723–2737.
Chen YJ, Dominguez-Brauer C, Wang Z, Asara JM, Costa RH, Tyner AL, 
Lau LF, Raychaudhuri P (2009). A conserved phosphorylation site within 
the forkhead domain of FoxM1B is required for its activation by cyclin-
CDK1. J Biol Chem 284, 30695–30707.
Chen X, Muller GA, Quaas M, Fischer M, Han N, Stutchbury B, Sharrocks 
AD, Engeland K (2013). The forkhead transcription factor FOXM1 
controls cell cycle-dependent gene expression through an atypical 
chromatin binding mechanism. Mol Cell Biol 33, 227–236.
Chen W, Yuan K, Tao ZZ, Xiao BK (2011). Deletion of forkhead Box M1 tran-
scription factor reduces malignancy in laryngeal squamous carcinoma 
cells. Asian Pac J Cancer Prev 12, 1785–1788.
Chetty C, Bhoopathi P, Rao JS, Lakka SS (2009). Inhibition of matrix metallo-
proteinase-2 enhances radiosensitivity by abrogating radiation-induced 
FoxM1-mediated G2/M arrest in A549 lung cancer cells. Int J Cancer 
124, 2468–2477.
Cho RJ et al. (1998). A genome-wide transcriptional analysis of the mitotic 
cell cycle. Mol Cell 2, 65–73.
Cho RJ, Huang M, Campbell MJ, Dong H, Steinmetz L, Sapinoso L, 
Hampton G, Elledge SJ, Davis RW, Lockhart DJ (2001). Transcriptional 
regulation and function during the human cell cycle. Nat Genet 27, 
48–54.
Crawford DF, Piwnica-Worms H (2001). The G(2) DNA damage checkpoint 
delays expression of genes encoding mitotic regulators. J Biol Chem 
276, 37166–37177.
Dai B, Kang SH, Gong W, Liu M, Aldape KD, Sawaya R, Huang S (2007). 
Aberrant FoxM1B expression increases matrix metalloproteinase-2 
transcription and enhances the invasion of glioma cells. Oncogene 26, 
6212–6219.
Dennis G Jr, Sherman BT, Hosack DA, Yang J, Gao W, Lane HC, Lempicki RA 
(2003). DAVID: Database for Annotation, Visualization, and Integrated 
Discovery. Genome Biol 4, P3.
Doong H, Price J, Kim YS, Gasbarre C, Probst J, Liotta LA, Blanchette J, 
Rizzo K, Kohn E (2000). CAIR-1/BAG-3 forms an EGF-regulated ternary 
complex with phospholipase C-gamma and Hsp70/Hsc70. Oncogene 
19, 4385–4395.
Down CF, Millour J, Lam EW, Watson RJ (2012). Binding of FoxM1 to G2/M 
gene promoters is dependent upon B-Myb. Biochim Biophys Acta 1819, 
855–862.
Eisen MB, Spellman PT, Brown PO, Botstein D (1998). Cluster analysis and 
display of genome-wide expression patterns. Proc Natl Acad Sci USA 
95, 14863–14868.
Fenton TR, Gout IT (2011). Functions and regulation of the 70 kDa ribo-
somal S6 kinases. Int J Biochem Cell Biol 43, 47–59.
ACKNOWLEDGMENTS
This work was supported by the V Foundation for Cancer Research, 
ACS-IRG 82-003-17, and National Institutes of Health Grants R01 
CA130795, R01 HG004499, and R25 CA134286. C.C. is supported 
by the start-up funding package provided by the Geisel School of 
Medicine at Dartmouth College.
Technologies) following the manufacturer’s protocol. Tissue culture 
dishes were sealed with glass coverslips and silicone grease and 
transferred to the LumiCycle (Actimetrics, Wilmette, IL) at 36°C. 
Data analysis was performed with LumiCycle Analysis software 
(Actimetrics).
Western blots
Antibodies to FoxM1 C-20 (1:500) and cyclinB1 H-433 (1:2000) were 
purchased from Santa Cruz Biotechnology. Anti–glyceraldehyde-3-
phosphate dehydrogenase was purchased from American Research 
Products (Belmont, MA). Western blots were run following standard 
protocols.
Plasmid construction
FOXM1 expression vectors, the ACAP3/CENTB5, and the RPS6KB1 
promoter constructs have been described previously (Grant et al., 
2012). We obtained commercially available promoter constructs for 
PLK1 (S119035), CENPE (S118567), TOP2A (S118760), and RMI1 
(S113323) from Switchgear Genomics (Menlo Park, CA).
The FOXM1 target promoter construct, pGL3-MCM8, was 
cloned based on ChIP-seq loci as determined by MACS. Primers 
were designed using Primer 3 (Rozen and Skaletsky, 2000) to pro-
vide an amplicon length between 800 and 1000 base pairs. DNA 
fragments were amplified via PCR and cloned into Zero Blunt TOPO 
(Life Technologies) before being subcloned into pGL3-basic 
(Promega, Madison, WI) using standard methods. All plasmids were 
verified by sequencing (Molecular Biology and Proteomics Core 
Facility, Dartmouth College).
Functional annotation
Functional annotation of genes was performed using DAVID (Dennis 
et al., 2003; Huang da et al., 2009).
Cell cycle–wide binding profiles
We investigated the distribution of transcription factor target genes 
in the cell cycle. First, we identified a list of 2830 cell cycle probes in 
U2OS cells and sorted them according to their peak expression time 
in the cell cycle. Then we examined the enrichment of the target 
genes of a given transcription factor in each sliding window of the 
cell cycle. We used a window size of 30° with 10° overlap between 
neighboring windows. We used Fisher’s exact test to determine the 
significance of enrichment of target genes for a transcription factor 
in each cell cycle window.
The target genes for E2F1, E2F4, and E2F6 in HeLa cells were 
determined from ChIP-seq data generated by the ENCODE project 
(Gerstein et al., 2012). The FOXM1 target genes were determined 
from the ChIP-seq presented here.
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